Journals / Türk Oftalmoloji Dergisi / 2017 / Cilt: 47 - Sayı: 4

Atypical Central Serous Chorioretinopathy

Atipik Santral Seröz Koryoretinopati

Pages
238–242
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The purpose of this study was to report diagnosis and treatment results of an unusual case of bullous CSCR induced by systemic and periocular corticosteroid therapy received at another medical center due to a misdiagnosis of Vogt-Koyanagi-Harada disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Bullous central serous chorioretinopathy (CSCR) is a rare variant of CSCR characterized by severe serous retinal detachment which especially involves the inferior quadrants.
📊
Key Findings & Data:Corticosteroid therapy administered for systemic or ocular misdiagnoses may induce and exacerbate CSCR.
💡
Conclusion & Impact:The purpose of this study was to report diagnosis and treatment results of an unusual case of bullous CSCR induced by systemic and periocular corticosteroid therapy received at another medical center due to a misdiagnosis of Vogt-Koyanagi-Harada disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Bullous central serous chorioretinopathy (CSCR) is a rare variant of CSCR characterized by severe serous retinal detachment which especially involves the inferior quadrants. Corticosteroid therapy administered for systemic or ocular misdiagnoses may induce and exacerbate CSCR. The purpose of this study was to report diagnosis and treatment results of an unusual case of bullous CSCR induced by systemic and periocular corticosteroid therapy received at another medical center due to a misdiagnosis of Vogt-Koyanagi-Harada disease.

Özet

Büllöz santral seröz koryoretinopati (SSKR); nadir görülen bir SSKR çeşididir ve özellikle retinada alt kadranlarda belirgin olan serözretina dekolmanı ile karakterizedir. Yanlış sistemik veya oküler hastalık ön tanısı ile uygulanan kortikosteroid, SSKR’nin ortaya çıkmasınaveya hastalığın daha ciddi şekle dönüşmesine sebep olabilir. Bu olgu sunumunda, kliniğimize başvurudan önce Vogt-Koyanagi-Haradahastalığı tanısı konularak sistemik ve perioküler kortikosteroid tedavisi almış olan ve buna bağlı olarak SSKR’nin nadir şekli olan büllöztipiyle tarafımıza başvuran bir hastanın tanı ve tedavi sonucunun sunulması amaçlanmıştır.

🔖

Cite This Article

TUTKUN, İ. T., CEBECİ, Z., BAYRAKTAR, Ş., KIR, N., ORAY, M. (2022). Atypical Central Serous Chorioretinopathy. Türk Oftalmoloji Dergisi, Cilt: 47 - Sayı: 4, 238–242. https://ajindex.com/articles/637847

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Salz DA, Pitcher JD, Hsu J, Regillo CD, Fineman MS, Elliott KS, Vander JF, Fischer DH, Spirn MJ. Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case series. Ophthalmic Surg Lasers Imaging Retina. 2015;46:439-444.
  2. Singh RP, Sears JE, Bedi R, Schachat AP, Ehlers JP, Kaiser PK. Oral eplerenone for the management of chronic central serous chorioretinopathy. Int J Ophthalmol. 2015;8:310-314.
  3. Smretschnig E, Ansari-Shahrezaei S, Hagen S, Glittenberg C, Krebs I, Binder S. Half-fluence photodynamic therapy in chronic central serous chorioretinopathy. Retina. 2013;33:316-323.
  4. Ng WW, Wu ZH, Lai TY. Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report. J Med Case Rep. 2011;26:208. Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol. 2003;87:1453-1458.
  5. Chhablani J, Wong IY, Kozak I. Choroidal imaging: A review. Saudi J Ophthalmol. 2014;28:123-128.
  6. Cunningham ET Jr, Rathinam SR, Tugal-Tutkun I, Muccioli C, Zierhut M. Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2014;22:249-252.
  7. Gao X, Li X. Development of bullous retinal detachment during systemic corticosteroid treatment. Graefes Arch Clin Exp Ophthalmol. 2011;249:1905- 1907.
  8. Kang JE, Kim HJ, Boo HD, Kim HK, Lee JH. Surgical management of bilateral exudative retinal detachment associated with central serous chorioretinopathy. Korean J Ophthalmol. 2006;20:131-138.
  9. Khairallah M, Kahloun R, Tugal-Tutkun I. Central serous chorioretinopathy, corticosteroids, and uveitis. Ocul Immunol Inflamm. 2012;20:76-85.
  10. Artunay HÖ, Rasier R, Yüzbaşıoğlu E, Şengül A, Şenel A, Bahçecioğlu H. Göz çevresi cilt bölgesine uygulanan topikal glukortikoid tedavisi sonrası gelişen akut bilateral santral seroz koryoretinopati. Turk J Ophthalmol. 2010;40:113-117.
  11. Karaçorlu M, Özdemir H. Intranazal steroid kullanımı sonrası santral seroz korioretinopati. Turk J Ophthalmol. 2005;35:72-74.
  12. Bouzas EA, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol. 2002;47:431-448.
  13. Gass JD, Little H. Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy. Ophthalmology. 1995;102:737-747.
  14. Otsuka S, Ohba N, Nakao K. A long-term follow-up study